Jump to main content.


Note: EPA no longer updates this information, but it may be useful as a reference or resource.


Docket Index

Docket No.

Filename

Title

Pages

42191

A1-001

Endocrine Disruptors; Notice of Public Meeting

2

42191

A1-002

Draft FR Notice - Endocrine Disruptors; Notice of Public Meeting to be held December 12 & 13, 1996

2

42191

A1-003

Draft FR Notice - Endocrine Disruptors; Notice of Public Meeting to be held February 5 & 6.

2

42193

A1-004

Endocrine Disruptors; Notice of Public Meeting Action: Notice of Public Meeting to begin on December 2-3, 1997

2

42191A

A1a-001

Endocrine Disruptors; Notice of Public Meeting Action: Notice of Public Meeting

2

42191B

A1b-001

Endocrine Disruptors; Notice of Public Meeting Action: Notice of Public Meeting

1

42191

B1-001

Endocrine Disruptor Screening and Testing Advisory Committee Charter

3

42191

B1-002

Endocrine Disruptor Screening and Testing Advisory Committee - Revised Mission Statement

1

42191

B1-003

EPA's Office of Water - Activities on Hormone Disruptors

1

42191

B1-004

Summary of the UK/USS Bilateral Meeting on Endocrine Disruption

11

42191

B1-005

Overview of USEPA's Office of Research & Development Activities: Endocrine Disruption by Chemicals; Next Steps in chemical screening and testing

12

42191

B1-006

Endocrine disruptor activities - Purpose: To summarize ongoing initiatives and activities within EPA - Handouts from organizational meeting.

26

42191

B1-007

EPA asking for comments on draft summary on May 15-16 meeting.

2

42191

B1-008

Opening remarks on endocrine disruptor by chemicals: Next steps in chemical screening and testing

8

42191

B1-009

Strawman mission statement for follow-up group

1

42191

B1-010

EPA desk statement on endocrine disruptors

1

42191

B1-011

Presentation given by M. Fry at May 15-16, 1996 meeting on endocrine disruptors

1

42191

B1-012

Potential issues for group discussion

1

42189

B1-013

Chemical Regulation Reporter: Illinois EPA identifies 74 substances as known, probable, or suspected EDC's.

2

42189

B1-014

TNRCC stands by Midlothian studies.

2

42189

B1-015

Responses to evaluation of the screening risk analysis for the TXI facility in Midlothian, Texas

7

42189

B1-016

Animal Health Survey Midlothian, Texas Region 6

32

42189

B1-017

Videotape - Dateline and various programs on toxic dangers in the community

0

42189

B1-018

Preparation for the upcoming Edstac Plenary Meeting

2

42189

B1-019

Intended to provide interested members of the public with an update on a variety of activities.

3

42189

B1-020

List of Edstac workgroup members. The disruptor screening and testing advisory committee.

1

42189

B1-021

Overslides and supplementary documents from Edstac meeting held February 5-6, 1997.

173

42189

B1-022

I-35 Corridor Cement Kiln Pollution Network Consensus Statement July, 1996.

13

42189

B1-023

A booklet on poison poles - a report about their toxic trail and the safer alternatives.

13

42189

B1-024

An article titled "An Ill Wind" - There's something in the air, and one family living near the TXI plant doesn't like it.

2

42189

B1-025

Booklet: Titled - Danger in the Air - Toxic Air Pollution in the Houston-Galveston corridor.

126

42189

B1-026

Booklet: Titled - The Most Powerful Polluters in Texas Understanding and Solving the Power Plant Threat to Public Health and Meeting Air Quality Standards.

22

42189

B1-027

North Kelly Gardens Community Health Survey near Kelly AFB, Texas

65

42189/90

B1-028

"Overview" - Title: Endocrine Disruptor by next steps in chemical screening and testing. (This document is on the Web site and TSCA hotline.)

15

42191A

B1a-001

Information about Endocrine Disruption and the Endocrine Disruptor Screening and Testing Advisory Committee

14

42191a

B1a-002

Discussion paper regarding the potential use of high throughput pre-screening as part of the EDSTAC conceptual framework

8

42191a

B1a-003

Attachment D "Overview of Polymer Review Process"

5

42191a

B1a-004

The Changing Burden of Regulation, Paperwork, and Tax Compliance on Small Business: A Report to Congress

49

42191A

B1a-005

Update on PSWG Activities related to the upcoming New York Plenary will have attached related to activities

3

42191A

B1a-005(1)

Attachment A(Proposed additions to the EDSTAC conceptual framework & overview), Attachment B (Proposal to "Hold" Polymers from screening and testing for endocrine disruption dated Oct. 2)

14

42191A

B1a-006

Definition of Endocrine Disruptor

3

42191A

B1a-007

Memorandum Subject: Roll-out strategy for the draft and final EDSTAC report in response to your request for guidance.

2

42191A

B1a-008

Chart-Alternative A Phase I--08/98...08/2000 Attachment A

3

42191A

B1a-009

Attachment B High Through-Put screening Draft discussion paper - Background

5

42197A

B1a-010

Attachment C Draft criteria for identifying chemical substances or mixtures that are "High Priority for Phase One"

4

42191A

B1a-011

Attachment E mixtures

4

42191A

B1a-012

Molecular Weitht (MW)

6

42191A

B1a-013

The STWG is charged with drafting

19

42191A

B1a-014

Recommendations for EDSTAC's draft Attachment C - Strenghts, limitations, guiding principles, and data sources of effects and exposure-related information to be used in sorting and priority setting for endocrine disruptor screening and testing

37

42191A

B1a-015

Facts and figures on endometriosis

6

42191A

B1a-016

Case History: experiences

10

42191A

B1a-016

Endometriosis in rhesus monkeys (MACACA Mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

9

42191A

B1a-017

Brochure: What is endometriosis

0

42191A

B1a-018

Brochure: Materials to help you

10

42191

C1-001

Comments for public meeting regarding the formation of endocrine disruptor screening and testing advisory committee.

2

42191

C1-002

Testing - Endocrine issue.

1

42191/82

C1-003

Letter of EPA commenting on Edstac nominees

1

42189

C1-004

Comment submitted to Edstac public meeting of the American Lung Assn. Of Texas

5

42189

C1-005

Comment submitted to Edstac public meeting of Channelview, Texas

15

42189

C1-006

Public comments by Clean Air Program

11

42189

C1-007

Written comments presented at public meeting.

2

42189

C1-008

Written comments presented at public meeting.

2

42189

C1-009

Comment submitted to Edstac public meeting from Houston, Texas.

3

42189

C1-010

Enclosed you will find for filing in the above referenced certain public comments made by M.O.S.E.S.

16

42192A

C1a-001

EDSTAC public comment period, Baltimore, MD

1

42192a

C1a-002

Contribution for public comment session of EDSTAC advisory committee

2

42192a

C1a-003

Testimony

5

42192a

C1a-004

Testimony on several people in CMA

3

42192a

C1a-005

Testimony on Endocrine Disruptors Screening and Testing Advisory Committee

4

42192a

C1a-006

1

42192a

C1a-007

Testimony on Endocrine Disruptors Screening and Testing Advisory Committee

132

42192a

C1a-008

Through M.O.S.E.S., poor, rural and/or minority communities fight back against polluters and Government to protect their children from the anguish and hoplessness of toxic exposure. Attach: Doll represent waste babies

14

42192a

C1a-009

Testimony

1

42192a

C1a-010

Comment

3

42192a

C1a-011

Comments for EPA meeting EDSTAC

1

42192a

C1a-012

Comment

1

42192a

C1a-013

Testimony

3

42192a

C1a-014

Comment

1

42192a

C1a-015

Public Comment

11

42192a

C1a-016

Student physicans for social responsibility statement regarding endocrine disruptors chemicals

1

42192a

C1a-017

Public Comment

1

42192a

C1a-018

Implications for reclassifying carcinogenic pesticides which may also be endocrine disruptors

2

42192a

C1a-019

Comment

1

42192a

C1a-020

Public Comment

4

42192a

C1a-021

Public Comment

1

42192a

C1a-022

Comments on EDSTAC's Draft document on Endocrine Disruptor Screening and Test strategies

1

42192a

C1a-023

Comment

19

42192a

C1a-024

Comment

3

42192a

C1a-025

This letter is a written transcript of my comments at the EDSTAC meeting in New York City on October 7, 1997

3

42191

D1-001

Participant list for Endocrine Disruptor Screening & Test Advisory Committee - Organizational Meeting, October 31 and November 1, 1996.

11

42191

D1-002

Participant list from Endocrine Disruptor follow-up meeting held.

3

42191

D1-003

Final participants list from May meeting on Endocrine Disruption by chemicals. Next steps in chemical screening and testing.

3

42191

D1-004

Endocrine Disruption by chemicals. Next steps in chemical screening and testing location Sheraton Crystal City (Observer Participant List).

10

42191

D1-005

Mailing list for materials from EPA meeting held on May 15-16, 1996.

7

42191

D1-006

Endocrine Disruption by chemicals. Next steps in chemical screening and testing. Open meeting.

2

42191

D1-007

Transcript of Public Meeting held May 15 & 16, 1996 on Endocrine Disruption by chemicals 2 volumes held in Ballroom C.

220

42189

D1-008

Edstac 3rd Plenary Meeting - April 29 ABD 30 - Draft Agenda.

2

42189

D1-009

Summary of Edstac Plenary Meeting held in Houston, Texas on February 5-6, 1997

15

42189

D1-010

Edstac Plenary - Attachment A Committee Member in Attendance Sheet.

2

42189

D1-011

Statement presented at Public Meeting.

2

42189

D1-012

Statement presented at Public Meeting.

11

42189

D1-013

Statement presented at Public Meeting.

4

42189

D1-014

Statement presented at Public Meeting.

3

42189

D1-015

Statement presented at Public Meeting.

6

42189

D1-016

Statement presented at Public Meeting.

3

42189

D1-017

Statement presented at Public Meeting.

2

42189

D1-018

Statement presented at Public Meeting.

2

42191A

D1a-001

CPDA's testimony from the October 7 EDSTAC meeting enclosed is the US small business admin. report referenced in the testimony

4

42191A

D1a-002

Endocrine Disruptor Screening and Testing Advisory Committee EDSTAC Fifth Plenary Meeting Draft Agenda Oct. 7-8, 1997 Laguardia Marriott, New York

2

42191A

D1a-003

Endocrine Disruptor Screening and Testing Advisory Committee Plenary Meeting July 15-16, 1997 Chicago, Illinois meeting summary.

13

42191A

D1a-004

Attachment A - Endocrine Disruptors Screening and Testing Advisory Committee (EDSTAC) Attendees to July 14-15, 1997 Meeting Chicago, IL

1

42191A

D1a-005

13

42191A

D1a-006

Endocrine Disruptor and testing advisory committee public comment sign in sheet

3

42191A

D1a-007

CPDA EDSTAC testimony

2

42191A

D1a-008

EDSTAC Committee Meeting - New York

3

42191A

D1a-009

The need for science-based policy and effective screening for environmental estrogens

1

42191A

D1a-010

EDSTAC meeting testimony

1

42191A

D1a-011

Endocrine Disruption Screening and Testing Advisory Committee

5

42191A

D1a-012

Comments at EPA Endocrine Disruption Screening and Testing Advisory Committee Meeting

2

42191A

D1a-013

The EDSTAC Public Comment Period

3

42191A

D1a-014

Forum on October 7 - NYC

5

42191A

D1a-015

Brochure, from Community Action Guide and a video was created for use

23

42191A

D1a-016

St. Mary Magdalen 96-97 Elementary School

2

42191A

D1a-017

Listing of MSDS sheets for field and grounds; Lyman High School

2

42191A

D1a-018

EDSTAC Comments

3

42191A

D1a-019

Endocrine Disruptor Screening and Testing Advisory Committee Public Comment Sign-in-Sheet

1

42191A

D1a-020

Testimony/Comments

2

42191A

D1a-021

Testimony/Comments

2

42191A

D1a-022

Testimony/Comments

2

42191A

D1a-023

Public Comment Session, EDSTAC Meeting

1

42191A

D1a-024

Re: Lawn vs. Man-Made Endocrine Disruptors

5

42191A

D1a-025

Testimony before the U.S. EPA's Endocrine Disruptors Screening and Testing Advisory Committee

5

42191A

D1a-026

Comments before the EDSTAC committee

2

42191A

D1a-027

Testimony

4

42191A

D1a-028

Statement on Endocrine Disruptors

2

42191A

D1a-029

Testimony

2

42191A

D1a-030

A Short History of How we got where we are today/testimony

6

42191A

D1a-031

Statement to the Endocrine Disruptors of EPA

4

42191A

D1a-032

Plenary Meeting October 7-8, 1997 New York - "Final Meeting Summary"

18

42191

E1-001

Screening tools for endocrine disruptors

2

42191

E1-002

Letter to stakeholders informing them of a Public Meeting to be held October 31 and November 1, 1996.

2

42191

E1-003

Enclosing Draft Summary on May 15-16 meeting on endocrine disruptors

2

42191

E1-004

Letter announcing that EPA was convening a meeting on May 15 & 16, 1996 endocrine disruption recipients: McCarthy, J. American Crop Protection Assn., Quance, J. Exxon, Fry M., University of California, Johnson B., Center for Disease Control, Damstra T. ,National Institute of Environmental & Health Sciences, Foster P., Chemical Industry Institute of Technology, Lebeau J., Dow Chemical Co., P. M. Bolger, FDA, Kendall R., Clemson University, Coborn T. ,World Wildlife Fund, Ohanian E., EPA Office of Water, Reiter L., EPA in RTP, Cagan S., Shell Chemical, Kim N., NY State Dept. Of Health Assessment, Dickson K., University of N. Texas, Weus J., Rutgers University, Lamb D., Baylor College of Medicine.

33

42189

E1-005

Two letters regarding Edstac from Gary Timm to T. Tweedale and M. Goldman.

5

42189

E1-006

A letter forwarding several reports and memoranda for committee review.

1

42189

E1-007

Letter potential health risks associated with burning of hazardous wastes in cement kilns in Midlothian, Texas.

3

42189

E1-008

Request for assistance for health studies in areas potentially affected by industrial emissions or discharges in Midlothian, Texas.

2

42189

E1-009

Letter on health issues pertaining to burning of hazardous wastes in cement kilns in Midlothian, Texas.

2

42189

E1-010

Responses to the document "Questions that should be answered".

2

42189

E1-011

Responding to her concerns regarding air contaminant emissions.

2

42189

E1-012

Materials submitted by Texas Natural Resources Conservation Commission total of 9 attachments.

201

42189

E1-013

Review of cancer incidence data for Channelview area.

5

42191

F1-001

Ecological risk assessment estrogenic chemicals - preliminary recommendations to begin the process.

2

42191

F1-002

Ecological risk assessment estrogenic chemicals - preliminary recommendations to begin the process.

2

42189

F1-003

Re: Report of Down Syndrome cluster in three Texas counties, 1992-1994 in Hood, Somervell and Ellis counties.

27

42189

F1-004

Critical evaluation of the potential impact of emissions from Midlothian industries: A Summary Report, Office of Air Quality Toxicology and Risk Assessment Section.

104

42189

F1-005

Screening Risk Analysis for the Texas Industries (TXI) facility in Midlothian, Texas: Executive Summary.

15

42189

F1-006

Protocol for management and public distribution of Edstac documents via the Web site.

6

42189

F1-007

Evaluation of the screening risk analysis for the Texas Industry facility in Midlothian, Texas.

5

42191B

F1b-001

Endocrine Disruptor Screening and Testing Committee Draft Report

211


Local Navigation


Jump to main content.